[HTML] ccjm.org

[HTML][HTML] Baricitinib and dexamethasone for hospitalized patients with COVID-19

LH Calabrese, C Calabrese - Cleveland Clinic Journal of Medicine, 2021 - ccjm.org
The glucocorticoid dexamethasone is the standard of care in critically ill patients with COVID-
19 to suppress the inappropriately heightened inflammatory response (cytokine storm), but …
被引用次数：28 相关文章

Baricitinib and dexamethasone for hospitalized patients with COVID-19

LH Calabrese, C Calabrese - Cleveland Clinic journal of … - pubmed.ncbi.nlm.nih.gov
The glucocorticoid dexamethasone is the standard of care in critically ill patients with COVID-
19 to suppress the inappropriately heightened inflammatory response (cytokine storm), but …

Baricitinib and dexamethasone for hospitalized patients with COVID-19.

LH Calabrese, C Calabrese - Cleveland Clinic Journal of Medicine, 2021 - europepmc.org
The glucocorticoid dexamethasone is the standard of care in critically ill patients with COVID-
19 to suppress the inappropriately heightened inflammatory response (cytokine storm), but …